Company: SHPH
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0001493152-25-008300
Chunk: 678

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-26
Form: 10-K
Item: Item 2
Chunk 678
---
 number of shares of common stock underlying outstanding equity incentive awards
for each of our executive officers as of December 31, 2024:

    Option Awards  
    Stock Awards 
  
    Name 
    Grant Date 
    Number of Securities Underlying Unexercised Options Exercisable (#)  
    Number of Securities Underlying Unexercised Options Unexercisable (#)  
    Option Exercise Price ($)  
    Option Expiration Date  
    Number of Shares or Units of Stock not yet Vested (#))  
    Market Value of Shares or Units not yet Vested ($) 
  
    Mira Jung1 
    5/1/23 
          -  
         -  
         -  
         -  
     1,194  
    $1,026 
  
    Timothy Lorber2 
    6/13/24 
     -  
     -  
     -  
     -  
     28,455  
    $24,443 

    (1)
    These
    restricted stock units vest in two installments on the anniversary of the grant date.

(2)
These restricted stock units vest in three installments on the anniversary of the grant date.

2018
Equity Incentive Plan

Our
2018 Equity Incentive Plan provides for equity incentives to be granted to our employees, executive officers or directors and to key
advisers and consultants. Equity incentives may be in the form of stock options with an exercise price of not less than the fair market
value of the underlying shares as determined pursuant to the 2018 Equity Incentive Plan, restricted stock awards, other stock-based awards,
or any combination of the foregoing. The 2018 Equity Incentive Plan is administered by the Company’s compensation committee or,
alternatively, if there is no compensation committee, the Company’s board of directors. We have reserved 3,000,000 shares of our
common stock for issuance under the Plan, of which 1,187,189 shares have been granted under the Plan as of the date of this Annual Report.

Director
Compensation

Each
of our non-employee directors, pursuant to the terms of director agreements (the “Director Agreements”), between each of
the directors and the Company, receives compensation on an annual basis consisting of $25,000 in cash, payable in quarterly
installments